Trials / Completed
CompletedNCT01223625
Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- Odense University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 81 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to measure the effect of moderate and intensive lipid-lowering treatment with rosuvastatin on the endothelial function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin 5mg/day | Rosuvastatin 5mg/day |
| DRUG | Rosuvastatin 40mg/day | Rosuvastatin 40mg/day |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-06-01
- Completion
- 2010-06-01
- First posted
- 2010-10-19
- Last updated
- 2010-10-19
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01223625. Inclusion in this directory is not an endorsement.